Originally published in Boston Business Journal on January 26, 2022
For the second straight year, the amount of venture capital that was poured into Massachusetts-based life sciences companies has eclipsed all previous fundraising records, ringing in at $13.66 billion in 2021.
According to a report from the Massachusetts Biotechnology Council, an industry group better known as MassBio, local biopharma companies accounted for 36% of all life sciences investments in the U.S., with more than 200 companies bringing in capital across some 250 rounds.